Tara Dall
Family Medicine · Delafield, WINPI 1649243445
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $165,419 of the $229,985 with a category attached, or 71.9%. Amgen accounts for 80.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $110,803 and has fallen 93.9% since, to $6,736 in 2025. Among family medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 391 payments — averaging $588.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$185K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39K
- Sanofi-aventis U.S. LLC$4K
- Amarin Pharma, Inc.$918
- Novo Nordisk$197
- Novartis$196
- plus $91 from 3 others
What the payments were for
- Consulting fees$7,9523%
- Speaking & faculty fees$165,41972%
- Travel & lodging$49,26321%
- Food & beverage$7,3193%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 281 | $184,963 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 82 | $39,471 |
| Sanofi-aventis U.S. LLC | 3 | $4,149 |
| Amarin Pharma, Inc. | 4 | $918 |
| Novo Nordisk | 10 | $197 |
| Novartis | 6 | $196 |
| Galderma Laboratories, L.p. | 2 | $40 |
| AbbVie | 2 | $29 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$181,026
- CYCLOSET$38,317
- DISEASE STATE$4,102
- Vascepa$840
How this compares
$229,985 in reported general payments places this provider in the 95th percentile of 1,482 family medicine providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 54 | $38,475 |
| JardianceEmpagliflozin | 17 | $23,027 |
| VascepaIcosapent Ethyl | 37 | $22,268 |
| FarxigaDapagliflozin Propanediol | 15 | $15,737 |
| MounjaroTirzepatide | 11 | $13,509 |
| Ezetimibe | 95 | $2,198 |
| Icosapent Ethyl | 11 | $1,866 |
| Niacin ErNiacin | 26 | $1,622 |
| Colchicine | 19 | $761 |
| Metformin Hcl ErMetformin Hcl | 73 | $741 |
| Rosuvastatin Calcium | 46 | $465 |
| Levothyroxine Sodium | 17 | $25 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Delafield
- Jennifer ParsleyElk Mound$1.4M
- William PalinMilwaukee$693K
- Ryan AndrewsStevens Point$429K
- Mark JensonGreen Bay$204K
- James SamuelMount Pleasant$203K
- Daniel DuffyCedarburg$194K
- Scott PeschkePlymouth$193K
- Gary JohnsonMadison$178K
- Patricia DemeryKaukauna$149K
- Jose DiasAppleton$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.